Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis

Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON. Methods This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjec...

Full description

Saved in:
Bibliographic Details
Published inDocumenta ophthalmologica Vol. 145; no. 3; pp. 185 - 195
Main Authors Kleerekooper, I., Del Porto, L., Dell’Arti, L., Guajardo, J., Leo, S., Robson, A. G., Trip, S. A., Petzold, A., Plant, G. T., Holder, G. E.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2022
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0012-4486
1573-2622
1573-2622
DOI10.1007/s10633-022-09896-6

Cover

Abstract Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON. Methods This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data. Results Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p  < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes ( p  < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity ( p  = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness ( r s  = 0.36; p  = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness ( r s  = 0.44, p  = 0.022). Conclusion PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.
AbstractList PurposeMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON.MethodsThis cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.ResultsTwenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).ConclusionPERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.
Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON.PURPOSEMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON.This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.METHODSThis cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).RESULTSTwenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.CONCLUSIONPERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.
Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON. This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data. Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (r  = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (r  = 0.44, p = 0.022). PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.
Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON. Methods This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data. Results Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p  < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes ( p  < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity ( p  = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness ( r s  = 0.36; p  = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness ( r s  = 0.44, p  = 0.022). Conclusion PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.
Author Trip, S. A.
Del Porto, L.
Robson, A. G.
Leo, S.
Guajardo, J.
Petzold, A.
Plant, G. T.
Kleerekooper, I.
Dell’Arti, L.
Holder, G. E.
Author_xml – sequence: 1
  givenname: I.
  orcidid: 0000-0001-6456-9034
  surname: Kleerekooper
  fullname: Kleerekooper, I.
  email: Iris.kleerekooper.18@ucl.ac.uk
  organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology, Institute of Neurology, University College London, MS Centre
– sequence: 2
  givenname: L.
  surname: Del Porto
  fullname: Del Porto, L.
  organization: Moorfields Eye Hospital, The Royal Victorian Eye and Ear Hospital Melbourne
– sequence: 3
  givenname: L.
  surname: Dell’Arti
  fullname: Dell’Arti, L.
  organization: Moorfields Eye Hospital, Foundation IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Ophthalmological Unit
– sequence: 4
  givenname: J.
  surname: Guajardo
  fullname: Guajardo, J.
  organization: Moorfields Eye Hospital, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo
– sequence: 5
  givenname: S.
  surname: Leo
  fullname: Leo, S.
  organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology
– sequence: 6
  givenname: A. G.
  surname: Robson
  fullname: Robson, A. G.
  organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology
– sequence: 7
  givenname: S. A.
  surname: Trip
  fullname: Trip, S. A.
  organization: Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology
– sequence: 8
  givenname: A.
  surname: Petzold
  fullname: Petzold, A.
  organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology, Dutch Expertise Centre for Neuro-Ophthalmology and MS Centre, Departments of Neurology and Ophthalmology, Amsterdam UMC
– sequence: 9
  givenname: G. T.
  surname: Plant
  fullname: Plant, G. T.
  organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology
– sequence: 10
  givenname: G. E.
  surname: Holder
  fullname: Holder, G. E.
  organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36161379$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9rFTEUxYNU7OvTL-BCAm7cjN4kM8lkKaVWoaCIrkMmc-eZMi955o_Qb2-eryp00VW45Hdyc865IGchBiTkJYO3DEC9ywykEB1w3oEetezkE7JhgxIdl5yfkQ0A413fj_KcXOR8CwBasfEZOReSSSaU3pDliy0FU6BXX68zzXW3w1yopYeYs59WpAmLD3alLoaS_FSLj4GWSMsPpL98ru3KuurLHV2bhPpwHAvSeCje0YA1-eLzc_J0sWvGF_fnlnz_cPXt8mN38_n60-X7m84JNZQOJaCW2qJ1g5RcCKbdNE5MDWIG1c9zzzTMC7dWjwiKz2Ieej4vo2ATQBu35M3p3UOKP2uzYvY-O1xXGzDWbHjzL0VbMTb09QP0NtbUrB4pMQxKDi3dLXl1T9Vpj7M5JL-36c78TbAB_AS41PwnXP4hDMyxJnOqybSazJ-ajGyi8YHI-WKP0ZZk_fq4VJykue0JO0z_v_2I6jfsTKZd
CitedBy_id crossref_primary_10_1136_bmjopen_2023_076651
crossref_primary_10_1007_s00415_023_11709_y
crossref_primary_10_1038_s41433_024_03154_6
crossref_primary_10_3390_biom15020158
crossref_primary_10_1167_tvst_13_2_18
Cites_doi 10.3390/ijms22073419
10.1371/journal.pone.0078341
10.1076/soph.18.2.50.15855
10.1177/2055217319871582
10.1023/A:1001844021014
10.1001/jama.1945.02860150014003
10.1016/S1474-4422(13)70259-X
10.1016/S1350-9462(00)00030-6
10.1038/nrneurol.2014.108
10.1007/s10633-016-9553-y
10.1002/ana.24006
10.1136/jnnp.52.12.1364
10.1038/eye.1997.231
10.1001/jamaneurol.2013.1832
10.1371/journal.pone.0071145
10.1016/j.ophtha.2013.08.045
10.1136/jnnp-2013-306902
10.1155/2020/4734276
10.1093/brain/awq346
10.1371/journal.pone.0034823
10.1038/sj.eye.6701573
10.1007/s10633-013-9401-2
10.1093/brain/109.3.469
10.1093/brain/awq080
10.1136/bjophthalmol-2014-305518
10.1093/brain/aww219
10.1016/S0140-6736(72)91155-5
10.1136/bjo.71.3.166
10.1016/0013-4694(91)90014-U
10.1093/brain/110.2.405
10.1016/j.clinph.2018.06.012
10.1007/BF00927252
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s10633-022-09896-6
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-2622
EndPage 195
ExternalDocumentID 36161379
10_1007_s10633_022_09896_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: UCLH Biomedical Research Centre
  funderid: http://dx.doi.org/10.13039/501100012317
– fundername: National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology
  funderid: http://dx.doi.org/10.13039/501100012618
– fundername: European Committee for Treatment and Research in Multiple Sclerosis
  funderid: http://dx.doi.org/10.13039/100008659
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACNCT
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAK
LLZTM
M1P
M4Y
MA-
N2Q
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZOVNA
ZXP
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PUEGO
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c375t-e60e969aeac56623319cb8b1753d074dd4190df2aa98e072d3d542df831b002d3
IEDL.DBID BENPR
ISSN 0012-4486
1573-2622
IngestDate Fri Sep 05 07:52:12 EDT 2025
Mon Oct 06 17:31:19 EDT 2025
Wed Feb 19 02:26:06 EST 2025
Thu Apr 24 23:07:24 EDT 2025
Wed Oct 01 02:18:56 EDT 2025
Fri Feb 21 02:44:26 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Inner nuclear layer (INL)
Multiple sclerosis
Macular function
Optic neuritis
Optical coherence tomography (OCT)
Pattern electroretinography (PERG)
Pattern visual evoked potential (PVEP)
Language English
License 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-e60e969aeac56623319cb8b1753d074dd4190df2aa98e072d3d542df831b002d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6456-9034
PMID 36161379
PQID 2735576563
PQPubID 36417
PageCount 11
ParticipantIDs proquest_miscellaneous_2718639698
proquest_journals_2735576563
pubmed_primary_36161379
crossref_primary_10_1007_s10633_022_09896_6
crossref_citationtrail_10_1007_s10633_022_09896_6
springer_journals_10_1007_s10633_022_09896_6
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20221200
2022-12-00
20221201
PublicationDateYYYYMMDD 2022-12-01
PublicationDate_xml – month: 12
  year: 2022
  text: 20221200
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Netherlands
– name: Dordrecht
PublicationSubtitle The Journal of Clinical Electrophysiology and Vision - The Official Journal of the International Society for Clinical Electrophysiology and Vision
PublicationTitle Documenta ophthalmologica
PublicationTitleAbbrev Doc Ophthalmol
PublicationTitleAlternate Doc Ophthalmol
PublicationYear 2022
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Al-NosairyKOHorbrüggerMSchipplingSStructure-function relationship of retinal ganglion cells in multiple sclerosisInt J Mol Sci20212211410.3390/ijms22073419
RuckerCSheathing of the retinal veins in multiple sclerosisJAMA194512797097310.1001/jama.1945.02860150014003
KaushikMWangCYBarnettMHInner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritisPLoS ONE2013841110.1371/journal.pone.00783411:CAS:528:DC%2BC3sXhsFyrurbJ
KaufholdFZimmermannHSchneiderEOptic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosisPLoS ONE201310.1371/journal.pone.0071145239407063808533
KnierBSchmidtPAlyLRetinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosisBrain20161392855286310.1093/brain/aww21927581073
HokazonoKRazaASOyamadaMKPattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetryDoc Ophthalmol201312720121510.1007/s10633-013-9401-223892551
HolderGEElectrophysiological assessment of optic nerve diseaseEye2004181133114310.1038/sj.eye.6701573155345991:STN:280:DC%2BD2crmtFOhsQ%3D%3D
SaidhaSSycSSBIbrahimMMAPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomographyBrain201113451853310.1093/brain/awq34621252110
AbeggMDysliMWolfSMicrocystic macular edema: retrograde maculopathy caused by optic neuropathyOphthalmology201412114214910.1016/j.ophtha.2013.08.04524139122
ViswanathanSFrishmanLJRobsonJGThe uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activityInvestig Ophthalmol Vis Sci200041279728101:STN:280:DC%2BD3czps1agtw%3D%3D
GelfandJMCreeBANolanRMicrocystic inner nuclear layer abnormalities and neuromyelitis opticaJAMA Neurol20137062963310.1001/jamaneurol.2013.183223529376
MessengerWHildebrandtLMackensenFCharacterisation of uveitis in association with multiple sclerosisBr J Ophthalmol20159920520910.1136/bjophthalmol-2014-30551825170065
HolderGEThe incidence of abnormal pattern electroretinography in optic nerve demyelinationElectroencephalogr Clin Neurophysiol199178182610.1016/0013-4694(91)90014-U17017101:STN:280:DyaK3M%2FnvVamsw%3D%3D
HolderGEPattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunctionJ Neurol Neurosurg Psychiatry1989521364136810.1136/jnnp.52.12.1364261443110315931:STN:280:DyaK3c7jt1OhtA%3D%3D
PlantGTHessRFThomasSJThe pattern evoked electroretinogram in optic neuritis: a combined psychophysical and electrophysiological studyBrain198610946948910.1093/brain/109.3.4693719286
Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X
MauguiereFHolderGLuxonLOsseltonJBinnieCCooperRAbnormal waveforms and diagnostic yield of evoked potentialsClinical neurophysiology: EMG; nerve conduction and evoked potentials1995OxfordButterworth-Heinemann431481
BerningerTAHeiderWPattern electroretinograms in optic neuritis during the acute stage and after remissionGraefe’s Arch Clin Exp Ophthalmol199022841041410.1007/BF009272521:STN:280:DyaK3M%2FjtlWjsg%3D%3D
HallidayAMMcdonaldWIMushinJDelayed visual evoked response in optic neuritisLancet197229998298510.1016/S0140-6736(72)91155-5
WangMGuoHLiSElectrophysiological and structural changes in Chinese patients with LHONJ Ophthalmol202010.1155/2020/4734276337632377817228
Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458. https://doi.org/10.1038/nrneurol.2014.108
BalkLJCoricDKnierBRetinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyMult Scler J Exp Transl Clin2019520552173198715810.1177/2055217319871582
TewariePBalkLCostelloFThe OSCAR-IB consensus criteria for retinal OCT quality assessmentPLoS ONE201271710.1371/journal.pone.00348231:CAS:528:DC%2BC38XmsFKjur4%3D
HolderGEPattern electroretinography (PERG) and an integrated approach to visual pathway diagnosisProg Retin Eye Res20012053156110.1016/S1350-9462(00)00030-6113902581:STN:280:DC%2BD3MzitVKntQ%3D%3D
OdomJVBachMBrigellMISCEV standard for clinical visual evoked potentials: (2016 update)Doc Ophthalmol201610.1007/s10633-016-9553-y28032236
HolderGVotrubaMCarterAElectrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qterDoc Ophthalmol19999521722810.1023/A:10018440210141:STN:280:DC%2BD3c%2FgtVajtA%3D%3D
BalkLJTwiskJWRSteenwijkMDA dam for retrograde axonal degeneration in multiple sclerosis?J Neurol Neurosurg Psychiatry20148578278910.1136/jnnp-2013-306902244748221:STN:280:DC%2BC2czpvFWnsw%3D%3D
ParisiVCorrelation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s diseaseSemin Ophthalmol200318505710.1076/soph.18.2.50.1585514566623
DaviesALDesaiRABloomfieldPSNeurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAnn Neurol20137481582510.1002/ana.24006240382791:CAS:528:DC%2BC2cXht1ehsbc%3D
GreenAJMcQuaidSHauserSLOcular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationBrain20101331591160110.1093/brain/awq080204101462877904
LightmanSMcdonaldWIBirdACRetinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosisBrain198711040541410.1093/brain/110.2.4053567529
HolderGESignificance of abnormal pattern electroretinography in anterior visual pathway dysfunctionBr J Ophthalmol19877116617110.1136/bjo.71.3.166382826910411121:STN:280:DyaL2s7lslGltg%3D%3D
HolderGEThe pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyesEye19971192493410.1038/eye.1997.2319537157
MonsalvePRenSJiangHRetinal ganglion cell function in recovered optic neuritis: faster is not betterClin Neurophysiol20181291813181810.1016/j.clinph.2018.06.01229981956
M Wang (9896_CR28) 2020
P Tewarie (9896_CR19) 2012; 7
GE Holder (9896_CR21) 2004; 18
9896_CR2
TA Berninger (9896_CR17) 1990; 228
LJ Balk (9896_CR32) 2014; 85
AM Halliday (9896_CR22) 1972; 299
V Parisi (9896_CR24) 2003; 18
M Kaushik (9896_CR10) 2013; 8
B Knier (9896_CR11) 2016; 139
JM Gelfand (9896_CR8) 2013; 70
GE Holder (9896_CR20) 1989; 52
W Messenger (9896_CR6) 2015; 99
AJ Green (9896_CR7) 2010; 133
S Viswanathan (9896_CR13) 2000; 41
GT Plant (9896_CR15) 1986; 109
GE Holder (9896_CR16) 2001; 20
LJ Balk (9896_CR4) 2019; 5
F Kaufhold (9896_CR3) 2013
C Rucker (9896_CR33) 1945; 127
K Hokazono (9896_CR23) 2013; 127
S Lightman (9896_CR5) 1987; 110
S Saidha (9896_CR31) 2011; 134
KO Al-Nosairy (9896_CR25) 2021; 22
AL Davies (9896_CR34) 2013; 74
G Holder (9896_CR29) 1999; 95
P Monsalve (9896_CR27) 2018; 129
GE Holder (9896_CR14) 1991; 78
JV Odom (9896_CR18) 2016
9896_CR1
M Abegg (9896_CR9) 2014; 121
GE Holder (9896_CR12) 1987; 71
F Mauguiere (9896_CR30) 1995
GE Holder (9896_CR26) 1997; 11
References_xml – reference: GelfandJMCreeBANolanRMicrocystic inner nuclear layer abnormalities and neuromyelitis opticaJAMA Neurol20137062963310.1001/jamaneurol.2013.183223529376
– reference: KaushikMWangCYBarnettMHInner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritisPLoS ONE2013841110.1371/journal.pone.00783411:CAS:528:DC%2BC3sXhsFyrurbJ
– reference: SaidhaSSycSSBIbrahimMMAPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomographyBrain201113451853310.1093/brain/awq34621252110
– reference: HolderGESignificance of abnormal pattern electroretinography in anterior visual pathway dysfunctionBr J Ophthalmol19877116617110.1136/bjo.71.3.166382826910411121:STN:280:DyaL2s7lslGltg%3D%3D
– reference: KaufholdFZimmermannHSchneiderEOptic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosisPLoS ONE201310.1371/journal.pone.0071145239407063808533
– reference: TewariePBalkLCostelloFThe OSCAR-IB consensus criteria for retinal OCT quality assessmentPLoS ONE201271710.1371/journal.pone.00348231:CAS:528:DC%2BC38XmsFKjur4%3D
– reference: ViswanathanSFrishmanLJRobsonJGThe uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activityInvestig Ophthalmol Vis Sci200041279728101:STN:280:DC%2BD3czps1agtw%3D%3D
– reference: HokazonoKRazaASOyamadaMKPattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetryDoc Ophthalmol201312720121510.1007/s10633-013-9401-223892551
– reference: HolderGVotrubaMCarterAElectrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qterDoc Ophthalmol19999521722810.1023/A:10018440210141:STN:280:DC%2BD3c%2FgtVajtA%3D%3D
– reference: BerningerTAHeiderWPattern electroretinograms in optic neuritis during the acute stage and after remissionGraefe’s Arch Clin Exp Ophthalmol199022841041410.1007/BF009272521:STN:280:DyaK3M%2FjtlWjsg%3D%3D
– reference: MauguiereFHolderGLuxonLOsseltonJBinnieCCooperRAbnormal waveforms and diagnostic yield of evoked potentialsClinical neurophysiology: EMG; nerve conduction and evoked potentials1995OxfordButterworth-Heinemann431481
– reference: RuckerCSheathing of the retinal veins in multiple sclerosisJAMA194512797097310.1001/jama.1945.02860150014003
– reference: Al-NosairyKOHorbrüggerMSchipplingSStructure-function relationship of retinal ganglion cells in multiple sclerosisInt J Mol Sci20212211410.3390/ijms22073419
– reference: HolderGEThe incidence of abnormal pattern electroretinography in optic nerve demyelinationElectroencephalogr Clin Neurophysiol199178182610.1016/0013-4694(91)90014-U17017101:STN:280:DyaK3M%2FnvVamsw%3D%3D
– reference: KnierBSchmidtPAlyLRetinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosisBrain20161392855286310.1093/brain/aww21927581073
– reference: HolderGEThe pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyesEye19971192493410.1038/eye.1997.2319537157
– reference: BalkLJTwiskJWRSteenwijkMDA dam for retrograde axonal degeneration in multiple sclerosis?J Neurol Neurosurg Psychiatry20148578278910.1136/jnnp-2013-306902244748221:STN:280:DC%2BC2czpvFWnsw%3D%3D
– reference: DaviesALDesaiRABloomfieldPSNeurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAnn Neurol20137481582510.1002/ana.24006240382791:CAS:528:DC%2BC2cXht1ehsbc%3D
– reference: PlantGTHessRFThomasSJThe pattern evoked electroretinogram in optic neuritis: a combined psychophysical and electrophysiological studyBrain198610946948910.1093/brain/109.3.4693719286
– reference: WangMGuoHLiSElectrophysiological and structural changes in Chinese patients with LHONJ Ophthalmol202010.1155/2020/4734276337632377817228
– reference: GreenAJMcQuaidSHauserSLOcular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationBrain20101331591160110.1093/brain/awq080204101462877904
– reference: HolderGEElectrophysiological assessment of optic nerve diseaseEye2004181133114310.1038/sj.eye.6701573155345991:STN:280:DC%2BD2crmtFOhsQ%3D%3D
– reference: Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458. https://doi.org/10.1038/nrneurol.2014.108
– reference: MessengerWHildebrandtLMackensenFCharacterisation of uveitis in association with multiple sclerosisBr J Ophthalmol20159920520910.1136/bjophthalmol-2014-30551825170065
– reference: AbeggMDysliMWolfSMicrocystic macular edema: retrograde maculopathy caused by optic neuropathyOphthalmology201412114214910.1016/j.ophtha.2013.08.04524139122
– reference: MonsalvePRenSJiangHRetinal ganglion cell function in recovered optic neuritis: faster is not betterClin Neurophysiol20181291813181810.1016/j.clinph.2018.06.01229981956
– reference: HolderGEPattern electroretinography (PERG) and an integrated approach to visual pathway diagnosisProg Retin Eye Res20012053156110.1016/S1350-9462(00)00030-6113902581:STN:280:DC%2BD3MzitVKntQ%3D%3D
– reference: Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X
– reference: HolderGEPattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunctionJ Neurol Neurosurg Psychiatry1989521364136810.1136/jnnp.52.12.1364261443110315931:STN:280:DyaK3c7jt1OhtA%3D%3D
– reference: ParisiVCorrelation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s diseaseSemin Ophthalmol200318505710.1076/soph.18.2.50.1585514566623
– reference: LightmanSMcdonaldWIBirdACRetinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosisBrain198711040541410.1093/brain/110.2.4053567529
– reference: BalkLJCoricDKnierBRetinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyMult Scler J Exp Transl Clin2019520552173198715810.1177/2055217319871582
– reference: OdomJVBachMBrigellMISCEV standard for clinical visual evoked potentials: (2016 update)Doc Ophthalmol201610.1007/s10633-016-9553-y28032236
– reference: HallidayAMMcdonaldWIMushinJDelayed visual evoked response in optic neuritisLancet197229998298510.1016/S0140-6736(72)91155-5
– volume: 22
  start-page: 1
  year: 2021
  ident: 9896_CR25
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22073419
– volume: 8
  start-page: 4
  year: 2013
  ident: 9896_CR10
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0078341
– volume: 18
  start-page: 50
  year: 2003
  ident: 9896_CR24
  publication-title: Semin Ophthalmol
  doi: 10.1076/soph.18.2.50.15855
– volume: 5
  start-page: 205521731987158
  year: 2019
  ident: 9896_CR4
  publication-title: Mult Scler J Exp Transl Clin
  doi: 10.1177/2055217319871582
– volume: 95
  start-page: 217
  year: 1999
  ident: 9896_CR29
  publication-title: Doc Ophthalmol
  doi: 10.1023/A:1001844021014
– volume: 127
  start-page: 970
  year: 1945
  ident: 9896_CR33
  publication-title: JAMA
  doi: 10.1001/jama.1945.02860150014003
– ident: 9896_CR2
  doi: 10.1016/S1474-4422(13)70259-X
– volume: 20
  start-page: 531
  year: 2001
  ident: 9896_CR16
  publication-title: Prog Retin Eye Res
  doi: 10.1016/S1350-9462(00)00030-6
– ident: 9896_CR1
  doi: 10.1038/nrneurol.2014.108
– year: 2016
  ident: 9896_CR18
  publication-title: Doc Ophthalmol
  doi: 10.1007/s10633-016-9553-y
– volume: 74
  start-page: 815
  year: 2013
  ident: 9896_CR34
  publication-title: Ann Neurol
  doi: 10.1002/ana.24006
– volume: 52
  start-page: 1364
  year: 1989
  ident: 9896_CR20
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.52.12.1364
– volume: 11
  start-page: 924
  year: 1997
  ident: 9896_CR26
  publication-title: Eye
  doi: 10.1038/eye.1997.231
– volume: 70
  start-page: 629
  year: 2013
  ident: 9896_CR8
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2013.1832
– year: 2013
  ident: 9896_CR3
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0071145
– volume: 121
  start-page: 142
  year: 2014
  ident: 9896_CR9
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.08.045
– volume: 85
  start-page: 782
  year: 2014
  ident: 9896_CR32
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2013-306902
– year: 2020
  ident: 9896_CR28
  publication-title: J Ophthalmol
  doi: 10.1155/2020/4734276
– volume: 134
  start-page: 518
  year: 2011
  ident: 9896_CR31
  publication-title: Brain
  doi: 10.1093/brain/awq346
– volume: 7
  start-page: 1
  year: 2012
  ident: 9896_CR19
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0034823
– volume: 18
  start-page: 1133
  year: 2004
  ident: 9896_CR21
  publication-title: Eye
  doi: 10.1038/sj.eye.6701573
– volume: 127
  start-page: 201
  year: 2013
  ident: 9896_CR23
  publication-title: Doc Ophthalmol
  doi: 10.1007/s10633-013-9401-2
– volume: 109
  start-page: 469
  year: 1986
  ident: 9896_CR15
  publication-title: Brain
  doi: 10.1093/brain/109.3.469
– volume: 133
  start-page: 1591
  year: 2010
  ident: 9896_CR7
  publication-title: Brain
  doi: 10.1093/brain/awq080
– volume: 99
  start-page: 205
  year: 2015
  ident: 9896_CR6
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2014-305518
– volume: 139
  start-page: 2855
  year: 2016
  ident: 9896_CR11
  publication-title: Brain
  doi: 10.1093/brain/aww219
– volume: 299
  start-page: 982
  year: 1972
  ident: 9896_CR22
  publication-title: Lancet
  doi: 10.1016/S0140-6736(72)91155-5
– volume: 71
  start-page: 166
  year: 1987
  ident: 9896_CR12
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.71.3.166
– volume: 78
  start-page: 18
  year: 1991
  ident: 9896_CR14
  publication-title: Electroencephalogr Clin Neurophysiol
  doi: 10.1016/0013-4694(91)90014-U
– volume: 110
  start-page: 405
  year: 1987
  ident: 9896_CR5
  publication-title: Brain
  doi: 10.1093/brain/110.2.405
– start-page: 431
  volume-title: Clinical neurophysiology: EMG; nerve conduction and evoked potentials
  year: 1995
  ident: 9896_CR30
– volume: 129
  start-page: 1813
  year: 2018
  ident: 9896_CR27
  publication-title: Clin Neurophysiol
  doi: 10.1016/j.clinph.2018.06.012
– volume: 41
  start-page: 2797
  year: 2000
  ident: 9896_CR13
  publication-title: Investig Ophthalmol Vis Sci
– volume: 228
  start-page: 410
  year: 1990
  ident: 9896_CR17
  publication-title: Graefe’s Arch Clin Exp Ophthalmol
  doi: 10.1007/BF00927252
SSID ssj0009718
Score 2.3385847
Snippet Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular...
Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular...
PurposeMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 185
SubjectTerms Acuity
Antibodies
Cross-Sectional Studies
Electrodes
Electroretinography - methods
Evoked Potentials, Visual
Eye
Glycoproteins
Humans
Inflammatory diseases
Medicine
Medicine & Public Health
Multiple sclerosis
Myelin
Neuritis
Neurology
Oligodendrocyte-myelin glycoprotein
Ophthalmology
Optic nerve
Optic neuritis
Optic Neuritis - diagnosis
Optics
Original Research Article
Patients
Structure-function relationships
Tomography
Tomography, Optical Coherence - methods
Vision Disorders
Visual Acuity
Visual evoked potentials
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fS8MwEA46QXwRfzudEsE3LbRJmzaPQzaHMBFxsLeSNqkIox229e_3rks3ZSrYt5JcWi6Xyxfu7gsh1yrFIxc3jhGaO2AUxokYTzCZCh7Pk5nG2uHxoxhN_IdpMLVFYWWb7d6GJBtP_aXYTXCMOTLHlZEUjtgkWwHSeYEVT1h_RbUbetb_MgcOH8KWyvw8xvftaA1jrsVHm21nuEd2LV6k_cUE75MNkx-Q7bGNiB-S7KkhyMzp4Pm-pGX9ivEiqui8QGOfGYpVijhCk5NuL7eiVUEB-NGPt7KGJpXWgMXpDEToW46vlaEF-JKUIt0lsh4dkclw8HI3cuzdCU7Kw6AC1btGCqnArwJgYxxWWppECfJyakANWvuABHTGlJKRcUOmuQ58prOIe7hva35MOnmRm1NCjUjdNPNB3gR-kuiIZa4JXc8oCVgvEV3itSqMU0ssjvdbzOIVJTKqPQa1x43aY5C5WcrMF7Qaf_butTMT2yVWxoC7AjgsBYJ3ydWyGRYHRjxUbooa-3gRQDAhoy45Wczo8nNcANjloeyS23aKV4P__i9n_-t-TnYYmluTANMjneq9NhcAY6rksrHaTy3R5zs
  priority: 102
  providerName: Springer Nature
Title Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis
URI https://link.springer.com/article/10.1007/s10633-022-09896-6
https://www.ncbi.nlm.nih.gov/pubmed/36161379
https://www.proquest.com/docview/2735576563
https://www.proquest.com/docview/2718639698
Volume 145
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1573-2622
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009718
  issn: 0012-4486
  databaseCode: AFBBN
  dateStart: 19970301
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1573-2622
  dateEnd: 20241028
  omitProxy: true
  ssIdentifier: ssj0009718
  issn: 0012-4486
  databaseCode: 7X7
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1573-2622
  dateEnd: 20241028
  omitProxy: true
  ssIdentifier: ssj0009718
  issn: 0012-4486
  databaseCode: BENPR
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1573-2622
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009718
  issn: 0012-4486
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1573-2622
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0009718
  issn: 0012-4486
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED7aBMZexn4vXRc02NsmZku2bD2MkY20ZaOhlAWyJyNL8igEO2vs_f27c-SEUVa_2ZJsoZNOn3x33wG8M5aOXNJzr5zkOCk8z4UsyZkKrzjWlaPY4cuFulgm31bp6ggWQywMuVUOOrFX1K6x9I_8I26zKWLjVMnPm9-cskaRdXVIoWFCagX3qacYO4axIGasEYy_zBdX1wca3iwOullwPJioEEYTgumUJJum4JHOteLq363qDv68Yzvtt6Szx_AoYEk22wn_CRz5-ik8uAzW8mdQXfXkmTWbX59v2bb7RbYkZtimoYWw9owiGOkNvb96SHzF2oYhKGR_brYdFhnbIU5na2zCbmq6bT1rUM9YRlSYxIj0HJZn8x9fL3jIq8CtzNIWxRJ5rbRBnYtgTkhchbbMS-LsdIgonEsQJbhKGKNzH2XCSZcmwlW5jGlPd_IFjOqm9q-AeWUjWyXY3qdJWbpcVJHPotgbjTiwVBOIhyEsbCAdp9wX6-JAl0zDXuCwF_2wF9jm_b7NZke5cW_t00EyRVh-2-IwWSbwdl-MC4esIab2TUd14hzhmdL5BF7uJLr_nFQIhGWmJ_BhEPHh5f_vy8n9fXkNDwVNr94Z5hRG7W3n3yCkacspHGerbArj2fnP7_NpmLX4dClmfwELafQ1
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiDcLBYwEJ4hI7MSJDxXisWVLu6uqaqXegmM7qNIq2TYJiD_Hb2Mm6-wKVfTW3KLEjjUee77JeL4BeK0NuVzCBU5aEaBSuCDjoqDDVHhFkSot5Q5PZ3JyEn87TU434M-QC0PHKoc9sd-obW3oH_l7NLMJYuNEig-L84CqRlF0dSihoX1pBbvTU4z5xI599_sXunDNzt4XnO83nO-Ojz9PAl9lIDAiTVocZOiUVBp3IIQ2XKBOmiIriMHSon21NkabaUuutcpcmHIrbBJzW2YiIgtnBfZ7A7ZiESt0_rY-jWeHR2va3zTytoAH6AhJn7bjk_ekoBgqD0KVKRnIf03jJbx7KVbbm8Ddu3DHY1f2cals92DDVffh5tRH5x9AediTdVZsfPS1YU33g2JXTLNFTQtv7hhlTFIP_fl4X2iLtTVDEMp-njUdPtKmQ7-AzbEJO6votnWsxn3NMKLeJAamh3ByLRJ-BJtVXbknwJw0oSljbO-SuChsxsvQpWHktELcWcgRRIMIc-NJzqnWxjxf0zOT2HMUe96LPcc2b1dtFkuKjyvf3h5mJvfLvcnXyjmCV6vHuFAp-qIrV3f0TpQhHJQqG8Hj5YyuPickAm-RqhG8G6Z43fn_x_L06rG8hFuT4-lBfrA3238GtzmpWn8QZxs224vOPUc41RYvvM4y-H7dy-QvAxEtLg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVqq4ICivhVKMVE5gNbETJz4ghNoufdCqQlTaW0hsB1VaJdsmAfWv9dcxk3V2hSp6a26RH7HGM57PmRfAdm7oyiUdd8pKjkzheCpkQc5U-IShLi3FDp-cqoPz6GgST1bgZoiFIbfK4UzsD2pbG_pHvoNqNkZsHCu5U3q3iLO98efZJacKUmRpHcppzFnk2F3_wetb8-lwD_f6vRDj_R-7B9xXGOBGJnGLCwycVjrH0wdhjZDIj6ZIC8peaVG3WhuhvrSlyHOduiARVto4ErZMZUjazUqc9wGsJVJqcidMJsky4W8Sei0gOF6BlA_Y8WF7SpL1VPBAp1px9a9SvIV0b1lpe-U3fgyPPGplX-Zs9gRWXLUB6yfeLv8UyrM-TWfF9r9_bVjT_SKrFcvZrCaRmzpGsZI0Q-8Z70tssbZmCD_Z74umw6bcdHgjYFMcwi4qem0dq_FEM4ySblLupWdwfi_0fQ6rVV25l8CcMoEpIxzv4qgobCrKwCVB6HKNiLNQIwgHEmbGpzenKhvTbJmYmcieIdmznuwZjvmwGDObJ_e4s_fmsDOZF_QmW7LlCN4tmlFEye6SV67uqE-YIhBUOh3Bi_mOLj4nFUJumegRfBy2eDn5_9fy6u61vIV1FI7s2-Hp8Wt4KIjTeg-cTVhtrzr3BnFUW2z1DMvg531LyF-xpirI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pattern+ERGs+suggest+a+possible+retinal+contribution+to+the+visual+acuity+loss+in+acute+optic+neuritis&rft.jtitle=Documenta+ophthalmologica&rft.au=Kleerekooper%2C+I.&rft.au=Del+Porto%2C+L.&rft.au=Dell%E2%80%99Arti%2C+L.&rft.au=Guajardo%2C+J.&rft.date=2022-12-01&rft.issn=0012-4486&rft.eissn=1573-2622&rft.volume=145&rft.issue=3&rft.spage=185&rft.epage=195&rft_id=info:doi/10.1007%2Fs10633-022-09896-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10633_022_09896_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-4486&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-4486&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-4486&client=summon